# 2026-22553: Noramco Seeks Federal Approval to Import Marijuana and Methadone

2026-22553, Importer of Controlled Substances Application: Noramco, is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2026-11-05, effective Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on, or objections to the issuance of the proposed registration on or before December 7, 2026. Such persons may also file a written request for a hearing on the application on or before December 7, 2026.; PRIA reads it as touching household money (as of 2026-11-06).

- Canonical: https://policyrisk.com/federal-register/2026-22553
- As of: 2026-11-06
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-22553
- Title: Importer of Controlled Substances Application: Noramco
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 69884
- Published: 2026-11-05
- Effective: Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on, or objections to the issuance of the proposed registration on or before December 7, 2026. Such persons may also file a written request for a hearing on the application on or before December 7, 2026.
- Comments close: 2026-12-07
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-11-06

## In one line

Noramco Seeks Federal Approval to Import Marijuana and Methadone

## Summary

Noramco wants to become an official importer of some controlled substances like marijuana and methadone. People who make or apply to handle these drugs can share their thoughts or ask for a hearing by December 7, 2026. This move could affect companies dealing with these substances and involves a formal review process with no immediate cost changes announced.

## Abstract

Noramco has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

## Effects PRIA read

- Noramco applied to import listed controlled drugs: mixed, medium. On September 21, 2026, Noramco applied to be registered as an importer for the listed basic classes of controlled substances, including Gamma Hydroxybutyric Acid (code 2010, Schedule I), Marihuana (7360, Schedule I), Tetrahydrocannabinols (7370, Schedule I), Methadone-Intermediate (9254, Schedule I…
- Import planned of poppy straw concentrate: benefit, medium. Noramco plans to import Poppy Straw Concentrate (drug code 9670, Schedule II) to bulk manufacture other controlled substances and distribute them to its customers.
- Import planned of Tapentadol intermediate: benefit, medium. Noramco plans to import an intermediate form of Tapentadol (drug code 9780, Schedule II) to bulk manufacture Tapentadol for distribution to its customers.
- Registration excludes finished dosage imports: cost, low. The notice explicitly states that authorization will not extend to the import of Food and Drug Administration-approved or non-approved finished dosage forms for commercial sale.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22555](https://policyrisk.com/federal-register/2026-22555): Importer of Controlled Substances Application: Diamond Animal Health, Inc., 2026-11-05
- [2026-22289](https://policyrisk.com/federal-register/2026-22289): Bulk Manufacturer of Controlled Substances Application: AJNA Biosciences, 2026-11-02

## Sources
- [2026-22553 on federalregister.gov](https://www.federalregister.gov/documents/2026/11/05/2026-22553/importer-of-controlled-substances-application-noramco)
- [2026-22553 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-11-05/pdf/2026-22553.pdf)

## Related
- [Previous: 2026-22552, Notice of Open Meeting for the 2026-2027 EXIM Advisory Committee](https://policyrisk.com/federal-register/2026-22552)
- [Next: 2026-22554, Tribal Intergovernmental Advisory Committee Request for Member Nominations; Ext…](https://policyrisk.com/federal-register/2026-22554)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-22553 (as of 2026-11-06).